| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/16/2009 | WO2006091216A3 Target-specific compomers and methods of use |
| 04/16/2009 | WO2006088911A3 Sequence-specific detection of nucleotide sequences |
| 04/16/2009 | WO2006088910A3 Sequence-specific detection of nucleotide sequences |
| 04/16/2009 | WO2006086760A3 Diagnostic measurement of disease |
| 04/16/2009 | WO2006086345A3 Methods to treat or prevent hormone-resistant prostate cancer using sirna specific for protocadherin-pc, or other inhibitors of protocadherin-pc expression or activity |
| 04/16/2009 | WO2006086210A3 Methods and compositions for tagging and identifying polynucleotides |
| 04/16/2009 | WO2006083937A3 Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists |
| 04/16/2009 | WO2006080937A3 Screening assays for antimicrobial agents |
| 04/16/2009 | WO2006073449A3 Multiplex systems, methods, and kits for detecting and identifying nucleic acids |
| 04/16/2009 | WO2006072078A3 Bioproduction of astaxanthin using mutant carotenoid ketolase and cartonenoid hydroxylase genes |
| 04/16/2009 | WO2006072075A3 Genetic markers of schizophrenia |
| 04/16/2009 | WO2006063116A3 Bifunctional enzyme with ϝ-glutamyleysteine synthetase and glutathione synthetase activity and uses thereof |
| 04/16/2009 | WO2006055615A3 A method for single oxygen atom incorporation into digested peptides using peptidases |
| 04/16/2009 | WO2006052814A3 A mortierella alpina diacylglycerol acyltransferase for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
| 04/16/2009 | WO2006050346A3 Ultra high throughput capture lift screening methods |
| 04/16/2009 | WO2006046979A3 Feline infectious peritonitis (fip) and systemic multi-organ coronavirus biomarkers and screening methods |
| 04/16/2009 | WO2006045062A3 Pot1 alternative splicing variants |
| 04/16/2009 | WO2006042328A3 Treatment of cancer and compositions |
| 04/16/2009 | WO2006042281A3 Method for diagnosing tuberous sclerosis complex |
| 04/16/2009 | WO2006042136A3 Detection of nucleic acids to assess risk for creutzfeldt-jakob disease |
| 04/16/2009 | WO2006036943A3 Determination of molecular age by detection of ink4a/arf expression |
| 04/16/2009 | WO2006028999A3 Assessment of ctla-4 polymorphisms in ctla-4 blockade therapy |
| 04/16/2009 | WO2006026611A3 Reverse transcriptase mediated rna gene expression |
| 04/16/2009 | WO2006023972A3 cAMP REPORTERS |
| 04/16/2009 | WO2006023965A3 Analytical methods utilizing real-time energy/particle interaction-based determination techniques |
| 04/16/2009 | WO2006019637A3 An intelligent nanomedicine integrating diagnosis and therapy |
| 04/16/2009 | WO2006015369A3 Assays for identification of topoisomerase inhibitors |
| 04/16/2009 | WO2006014588A3 Nucleic acid end-labeling reagents |
| 04/16/2009 | WO2005123953A3 Genetic screening for polymorphisms in human genes that increase or decrease sensitivity to toxic agents |
| 04/16/2009 | WO2005121375A3 Detection of dna mismatches and oxidative lesions |
| 04/16/2009 | WO2005118787A3 Method of screening candidate compounds for susceptibility to biliary excretion |
| 04/16/2009 | WO2005116611A3 Flow assay device comprising dry reagent cake |
| 04/16/2009 | WO2005116240A3 System for amplyfing optical detection cantilever deflection |
| 04/16/2009 | WO2005113832A3 Wide field imager for quantitative analysis of microarrays |
| 04/16/2009 | WO2005112906A3 Method for augmenting the effects of serotonin reuptake inhibitors |
| 04/16/2009 | WO2005107364A3 Polynucleotide, polypeptides, and diagnostic methods |
| 04/16/2009 | WO2005094393A3 Methods and processes for attaching compounds to matrices |
| 04/16/2009 | WO2005094279A3 Immortalized human tuberous sclerosis null angiomyolipoma cell and method of use thereof |
| 04/16/2009 | WO2005091849A3 Mutations of the pik3ca gene in human cancers |
| 04/16/2009 | WO2005079380A3 Identification of soybeans having resistance to phytophthora sojae |
| 04/16/2009 | WO2005079276A3 Selective growth medium for listeria spp |
| 04/16/2009 | WO2005056761A3 REAGENTS AND METHODS FOR IDENTIFICATION OF RNAi PATHWAY GENES AND CHEMICAL MODULATORS OF RNAi |
| 04/16/2009 | WO2005049851A3 Methods, articles, and compositions for identifying oligonucleotides |
| 04/16/2009 | WO2005030983A3 Amplification of polynucleotides by rolling circle amplification |
| 04/16/2009 | WO2005025408A3 Assay for sars coronavirus by amplification and detection of nucleocapsid rna sequence |
| 04/16/2009 | WO2005024696A3 Method and system for clustering and rescaling for molecular analysis |
| 04/16/2009 | WO2005007806A3 Protein design for receptor-ligand recognition and binding |
| 04/16/2009 | WO2004064601A3 Amplified and overexpressed gene in colorectal cancers |
| 04/16/2009 | US20090100542 Promoter for epidermis-specific, pathogen-inducible transgenic expression in plants |
| 04/16/2009 | US20090100539 Nucleotide sequences and corresponding polypeptides conferring modulated growth rate and biomass in plants grown in saline conditions |
| 04/16/2009 | US20090100537 Methods and compositions for high yielding soybeans with nematode resistance |
| 04/16/2009 | US20090099826 Caspase-9:bir3 domain of xiap complexes and methods of use |
| 04/16/2009 | US20090099341 Heparanase specific molecular probes and their use in research and medical applications |
| 04/16/2009 | US20090099191 Inhibition of nf-kb |
| 04/16/2009 | US20090099134 Treatment of dna damage related disorders |
| 04/16/2009 | US20090099130 Methods and compositions for preventing and treating a disease related to glycan dysregulation |
| 04/16/2009 | US20090099110 Antiviral oligonucleotides |
| 04/16/2009 | US20090099107 Methods and Compositions for Inhibition of Nuclear Factor kappaB |
| 04/16/2009 | US20090099094 Use of Somatostatin Agonists to Treat Medullary Thyroid Carcinoma |
| 04/16/2009 | US20090099072 Motif of the Beclin Protein Which Interacts with Anti-Apoptotic Members of the Bcl-2 Protein Family, and Uses |
| 04/16/2009 | US20090099069 Modulators of alpha-synuclein toxicity |
| 04/16/2009 | US20090099062 Pyrvinium For The Treatment of Cancer |
| 04/16/2009 | US20090099038 Cell line, system and method for optical-based screening of ion-channel modulators |
| 04/16/2009 | US20090099037 Genomic Screen for Epigenetically Silenced Genes Associated With Cancer |
| 04/16/2009 | US20090099035 Oligonucleotide arrays for high resolution hla typing |
| 04/16/2009 | US20090099034 Reagents and Methods for miRNA Expression Analysis and Identification of Cancer Biomarkers |
| 04/16/2009 | US20090099033 In vitro screening and evolution of proteins |
| 04/16/2009 | US20090099030 Method of detecting mutations in the gene encoding cytochrome P450-2C9 |
| 04/16/2009 | US20090098632 Compositions comprising viruses and methods for concentrating virus preparations |
| 04/16/2009 | US20090098627 wherein mutant hydrolase forms stable bond with rhodococcus dehalogenase substrate; beta-lactamases; fusion proteins; cell labelling; tissue target therapy |
| 04/16/2009 | US20090098613 Method for synthesizing DNA |
| 04/16/2009 | US20090098610 useful as a reagent for genetic engineering, DNA sequencing, labeling, site-directed mutagenesi; culturing a cell capable of producing a polypeptide, and collecting such polypeptide from the culture |
| 04/16/2009 | US20090098609 Il-2 fusion proteins with modulated selectivity |
| 04/16/2009 | US20090098605 MUTATED TRUNCATED mt-pfkA GENE FOR THE SYNTHESIS OF ACTIVE SHORTER FRAGMENT OF 6-PHOSPHOFRUCTO-1-KINASE |
| 04/16/2009 | US20090098597 Method for quantifying cell motility and cell migration |
| 04/16/2009 | US20090098596 Photostable fret-competent biarsenical-tetracysteine probes based on fluorinated fluoresceins |
| 04/16/2009 | US20090098595 properly detect ovarian cancer at an early stage; biomarkers such as galectin-1, cathepsin B, MHC class I antigen, heat shock protein (HSP) 27, ubiquitin carboxy-termal esterase L1, plasma retinol-binding protein (PRBP), transthyretin, SH3 binding glutamate-rich protein, tubulin-specific chaperone A |
| 04/16/2009 | US20090098594 Methods for diagnosis prognosis and methods of treatment |
| 04/16/2009 | US20090098593 Laboratory plate thermal vault |
| 04/16/2009 | US20090098592 Method |
| 04/16/2009 | US20090098591 Method of Correlating Marker Molecule Concentration To A Specific Cell Potency Level in Chondrocyte Culture |
| 04/16/2009 | US20090098590 Endotoxin analysis |
| 04/16/2009 | US20090098589 Method |
| 04/16/2009 | US20090098588 Beta galactosidase donor fragments |
| 04/16/2009 | US20090098587 Method of screening for disorders of glucose metabolism |
| 04/16/2009 | US20090098586 Assay for Determination of Free D-galactose and/or L-arabinose |
| 04/16/2009 | US20090098585 Reagent kit for detecting lupus anticoagulant |
| 04/16/2009 | US20090098582 Method for determining risk of cancer relapse and computer program product |
| 04/16/2009 | US20090098580 Mammalian sweet taste receptors |
| 04/16/2009 | US20090098579 Using g-protein coupled receptor as tools in identifying modulators which improve palatability of low-calorie beverages through development of new artificial sweeteners; modulating taste perception |
| 04/16/2009 | US20090098577 Method of identifying compounds that modulate caspase 9 activity via use of a kosmotropic salt |
| 04/16/2009 | US20090098575 antiidiotypic, chimeric, humanized, monoclonal or polyclonal antibodies or faragments that specifically binds polypeptides having synthetase enzyme activity |
| 04/16/2009 | US20090098573 for use in designing and/or identifying modulators of insect behavior; biolgical pest control |
| 04/16/2009 | US20090098571 Methods and substances for the diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 04/16/2009 | US20090098569 Novel PGC-1 Isoforms and Uses Therefor |
| 04/16/2009 | US20090098567 Collection device |
| 04/16/2009 | US20090098566 Method of synthesizing nucleic acid |
| 04/16/2009 | US20090098565 MeCP2E1 gene |
| 04/16/2009 | US20090098564 Quantifying in RNA of a blood sample, a level of RNA and comparing with control; allows for an immediate and accurate diagnostic/prognostic test for disease or to assess the effect of a particular treatment regimen |
| 04/16/2009 | US20090098563 Diagnosis of (a risk of) disease and monitoring of therapy |